Pomalyst Capsules 4mg

Manufacturer
Celgene International Sarl(SWITZERLAND)

Registraction Number
MAL16015080ARZ

Content:
Pomalyst Capsules 4mg contain 4 mg of pomalidomide, which is an immunomodulatory agent used to treat multiple myeloma. Pomalidomide works by helping the immune system to attack cancer cells.
Indications:

• Multiple Myeloma: Treatment of adults with multiple myeloma who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor, and whose disease has progressed on or within 60 days of the last therapy.

1. Administration: Take orally, as directed by your doctor.
2. Dosage: Follow your doctor's prescription. The usual dose is 4 mg once daily on days 1-21 of a 28-day cycle.
3. Timing: Take it at the same time each day to help you remember.
4. Monitoring: Regular monitoring of blood counts and other parameters is essential.